A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis

Background and objective Pulmonary lymphangioleiomyomatosis (PLAM) is a rare tumor with unique clinicopathological features. The aim of this study is to investigate the clinicopathological features, the diagnosis and differential diagnosis of pulmonary lymphangioleiomyomatosis. Methods Three cases o...

Full description

Bibliographic Details
Main Authors: Jun GAO, Peiju ZHU, Shangfu ZHANG, Sha ZHAO, Changli LU, Huijiao CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.04.14&path[]=3740
id doaj-8de747527c7248188a04f72a4c164c70
record_format Article
spelling doaj-8de747527c7248188a04f72a4c164c702020-11-25T01:22:17ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872011-04-01144378382A Clinicopathological Analysis of Pulmonary LymphangioleiomyomatosisJun GAOPeiju ZHUShangfu ZHANGSha ZHAOChangli LUHuijiao CHENBackground and objective Pulmonary lymphangioleiomyomatosis (PLAM) is a rare tumor with unique clinicopathological features. The aim of this study is to investigate the clinicopathological features, the diagnosis and differential diagnosis of pulmonary lymphangioleiomyomatosis. Methods Three cases of PLAM were analyzed by light microscopy, immunohistochemistry and their clinical data, and the relative literatures were reviewed. Results Three cases of patients suffered from PLAM were the women in their reproductive aged, from 27 years to 45 years (mean 37.7 years), two cases of the HRCT showed bilateral diffuse cystic airspaces changed, and one case was the pneumothorax. The histopathological examination revealed the tumor was composed of the variably sized cystic spaces are lined by plaque-like or nodular aggregates of endothelial cells and the hyperplasia, smooth-muscle-like spindle cells which was along with the bronchi and the vessels. The immunohistochemistry showed that Des, Caldes, SMA, MSA, HMB-45, CD63, Vim, ER and PR were positive in the hyperplasia spindle cells, and there was no expression of MRAT-1. The FVIII, CD34 were positive in the capillary endothelial cells, and the D2-40 was positive in the lymphatic vessels. All the patients were alive without the recrudescence of the PLAM since the diagnosis, about 3 months to 25 months, and there was no LAM in their other systems. Conclusion The most significant histopathological feature of pulmonary lymphangioleiomyomatosis was the progressive invasion of smooth muscle cells into the lymphatic vessels, and the blood vessels. The majority of the cases occur in the lungs of the women in the predominantly premenopausal and middle-age. It is a poor prognosis due to the progressive respiratory failure.http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.04.14&path[]=3740Lung neoplasmsLymphangioleiomyomatosisImmunohistochemistryDiagnosis
collection DOAJ
language zho
format Article
sources DOAJ
author Jun GAO
Peiju ZHU
Shangfu ZHANG
Sha ZHAO
Changli LU
Huijiao CHEN
spellingShingle Jun GAO
Peiju ZHU
Shangfu ZHANG
Sha ZHAO
Changli LU
Huijiao CHEN
A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis
Chinese Journal of Lung Cancer
Lung neoplasms
Lymphangioleiomyomatosis
Immunohistochemistry
Diagnosis
author_facet Jun GAO
Peiju ZHU
Shangfu ZHANG
Sha ZHAO
Changli LU
Huijiao CHEN
author_sort Jun GAO
title A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis
title_short A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis
title_full A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis
title_fullStr A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis
title_full_unstemmed A Clinicopathological Analysis of Pulmonary Lymphangioleiomyomatosis
title_sort clinicopathological analysis of pulmonary lymphangioleiomyomatosis
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
series Chinese Journal of Lung Cancer
issn 1009-3419
1999-6187
publishDate 2011-04-01
description Background and objective Pulmonary lymphangioleiomyomatosis (PLAM) is a rare tumor with unique clinicopathological features. The aim of this study is to investigate the clinicopathological features, the diagnosis and differential diagnosis of pulmonary lymphangioleiomyomatosis. Methods Three cases of PLAM were analyzed by light microscopy, immunohistochemistry and their clinical data, and the relative literatures were reviewed. Results Three cases of patients suffered from PLAM were the women in their reproductive aged, from 27 years to 45 years (mean 37.7 years), two cases of the HRCT showed bilateral diffuse cystic airspaces changed, and one case was the pneumothorax. The histopathological examination revealed the tumor was composed of the variably sized cystic spaces are lined by plaque-like or nodular aggregates of endothelial cells and the hyperplasia, smooth-muscle-like spindle cells which was along with the bronchi and the vessels. The immunohistochemistry showed that Des, Caldes, SMA, MSA, HMB-45, CD63, Vim, ER and PR were positive in the hyperplasia spindle cells, and there was no expression of MRAT-1. The FVIII, CD34 were positive in the capillary endothelial cells, and the D2-40 was positive in the lymphatic vessels. All the patients were alive without the recrudescence of the PLAM since the diagnosis, about 3 months to 25 months, and there was no LAM in their other systems. Conclusion The most significant histopathological feature of pulmonary lymphangioleiomyomatosis was the progressive invasion of smooth muscle cells into the lymphatic vessels, and the blood vessels. The majority of the cases occur in the lungs of the women in the predominantly premenopausal and middle-age. It is a poor prognosis due to the progressive respiratory failure.
topic Lung neoplasms
Lymphangioleiomyomatosis
Immunohistochemistry
Diagnosis
url http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.04.14&path[]=3740
work_keys_str_mv AT jungao aclinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT peijuzhu aclinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT shangfuzhang aclinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT shazhao aclinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT changlilu aclinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT huijiaochen aclinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT jungao clinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT peijuzhu clinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT shangfuzhang clinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT shazhao clinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT changlilu clinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
AT huijiaochen clinicopathologicalanalysisofpulmonarylymphangioleiomyomatosis
_version_ 1725126690059845632